Long-term Response of Helicobacter pylori Antibody Titer After Eradication Treatment in Middle-aged Japanese: JPHC-NEXT Study

Long-term Response of Helicobacter pylori Antibody Titer After Eradication Treatment in Middle-aged Japanese: JPHC-NEXT Study

Background: Helicobacter pylori (H. pylori) is an established causative factor of gastric cancer. Although the expansion of insurance coverage has led to an increase in the number of patients treated for H. pylori, the population impact of eradication treatment for H. pylori has been scarcely invest...

Full description

Bibliographic Details
Main Authors: Shiori Tanaka, Atsushi Goto, Kazumasa Yamagishi, Motoki Iwasaki, Taiki Yamaji, Taichi Shimazu, Hiroyasu Iso, Isao Muraki, Nobufumi Yasuda, Isao Saito, Tadahiro Kato, Kiyoshi Aoyagi, Kazuhiko Arima, Kiyomi Sakata, Kozo Tanno, Manami Inoue, Norie Sawada, Shoichiro Tsugane
Format: Article
Language:English
Published: Japan Epidemiological Association 2023-01-01
Series:Journal of Epidemiology
Subjects:
helicobacter pylori
antibody
eradication treatment
cohort
japan
Online Access:https://www.jstage.jst.go.jp/article/jea/33/1/33_JE20200618/_pdf

Internet

https://www.jstage.jst.go.jp/article/jea/33/1/33_JE20200618/_pdf

Similar Items